(function(doc, html, url) { var widget = doc.createElement("div"); widget.innerHTML = html; var script = doc.currentScript; // e = a.currentScript; if (!script) { var scripts = doc.scripts; for (var i = 0; i < scripts.length; ++i) { script = scripts[i]; if (script.src && script.src.indexOf(url) != -1) break; } } script.parentElement.replaceChild(widget, script); }(document, '

Use of fenofibrate as adjuvant to phototherapy in unconjugated neonatal hyperbilirubinemia

What is it about?

This paper is a systematic review and meta-analysis examining the use of fenofibrate as an adjuvant to phototherapy in treating unconjugated neonatal hyperbilirubinemia. It analyzes the effects on total serum bilirubin levels and phototherapy duration. The study found that fenofibrate may help reduce bilirubin levels and shorten phototherapy time.

Why is it important?

This study is important because it explores the potential of fenofibrate to enhance phototherapy, a common treatment for neonatal jaundice. By reducing bilirubin levels faster and shortening phototherapy duration, it could lower hospitalization time, healthcare costs, and associated risks, benefiting both newborns and healthcare systems.

Read more on Kudos…
The following have contributed to this page:
Ari Viandri Wismananda
' ,"url"));